Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
ÌÇÐÄ´«Ã½
Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234 ADVANCES IN RADIATION ONCOLOGY Michikawa, C., Torres-Saavedra, P. A., Silver, N. L., Harari, P. M., Kies, M. S., Rosenthal, D. I., Le, Q., Jordan, R. C., Duose, D. Y., Mallampati, S., Trivedi, S., Luthra, R., Wistuba, I. I., Osman, A. A., Lichtarge, O., Foote, R. L., Parvathaneni, U., Hayes, D., Pickering, C. R., Myers, J. N. 2022; 7 (6)View details for
View details for